Indications for Digitalis Therapy: A New Look

Jay N. Cohn

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Abstract

The indications for use of digitalis as an inotropic agent have been reexamined in the context of recent emphasis on the toxicity of digitalis and current knowledge regarding the mechanisms of clinical congestive heart failure in various disease states. Digitalis may be overprescribed in patients in whom (1) the signs and symptoms of congestive heart failure are not due primarily to an impairment of myocardial contractility, (2) administration of digitalis is not associated with notable improvement in cardiac function, or (3) increases in contractility could have a deleterious effect on myocardial metabolism. There must be increased selectivity in the administration of digitalis to patients with heart disease and more emphasis on pharmacologic manipulation of other factors that control cardiac performance.

Original languageEnglish (US)
Pages (from-to)1911-1914
Number of pages4
JournalJAMA: The Journal of the American Medical Association
Volume229
Issue number14
DOIs
StatePublished - Sep 30 1974

Fingerprint Dive into the research topics of 'Indications for Digitalis Therapy: A New Look'. Together they form a unique fingerprint.

Cite this